Client Work

Medo DX PTE. Ltd. Sold to Exo Imaging

August 24, 2022

Exo Imaging, Inc. has purchased all outstanding shares of Medo DX PTE. Ltd., an artificial intelligence and machine learning company based in Singapore and Alberta that operates in the medical imaging sector in North America.

The Bennett Jones team acted as lead counsel and key advisor to Medo DX Pte. Ltd. and their Albertan subsidiary, Medo.ai Inc., in all aspects of this transaction, requiring substantial international coordination with multiple investor sellers in Singapore and navigating  the jurisdictions of Delaware, Singapore and Canada.

Read more about this sale on Business Wire.

 
Social Media
Download
Download
Subscribe
Republishing Requests

For permission to republish this or any other publication, contact Amrita Kochhar at kochhara@bennettjones.com.

For informational purposes only

This publication provides an overview of legal trends and updates for informational purposes only. For personalized legal advice, please contact the authors.